Beeline Medicines
Let's get to what matters
Boston, United States · Founded 2025
- Headquarters
- Boston
- Founded
- 2025
- Business Model
- B2B
- Website
- beelinemedicines.com
About
Beeline Medicines is a clinical-stage biotechnology company, created by Bristol Myers Squibb and Bain Capital in 2025, developing precision therapies that target the underlying drivers of autoimmune and inflammatory disease. Its lead program, afimetoran, is an oral TLR7/8 inhibitor in Phase 2 trials for systemic and cutaneous lupus with FDA Fast Track designation, alongside a pipeline including BLN-326 (an IL-2-CD25 fusion protein), lomedeucitinib (a TYK2 inhibitor), and two preclinical biologics. The company is headquartered in Boston, Massachusetts.
Summary
Beeline Medicines is a Biotech company based in Boston, United States, founded in 2025.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...